Pulmonary function of inhaled human insulin (Exubera®) in patients with type 2 diabetes: results from a 2-year study using standardized methodology Source: Eur Respir J 2006; 28: Suppl. 50, 742s Year: 2006
Pulmonary function of inhaled human insulin (Exubera®) in patients with type 1 diabetes: results from a 2-year study using standardized methodology Source: Eur Respir J 2006; 28: Suppl. 50, 613s Year: 2006
Decline of the lung function and quality of glycemic control in type 2 diabetes mellitus Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013
Association between type 2 diabetes, prediabetes and lung function: Results from the KORA cohort Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018
Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2? Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009
Pulmonary tuberculosis and diabetes mellitus: a reciprocal interaction Source: Eur Respir J 2007; 30: Suppl. 51, 664s Year: 2007
Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012
Are spirometry indices associated with microvascular complications in type 1 diabetes subjects? Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019
Lung function in children with juvenile diabetes type 1 Source: Eur Respir J 2002; 20: Suppl. 38, 139s Year: 2002
Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018
Respiratory muscle function in type 2 diabetes mellitus Source: Annual Congress 2008 - Assessment of the respiratory system Year: 2008
Relationship between the type of the obesity and pulmonary function test abnormalities Source: Eur Respir J 2004; 24: Suppl. 48, 336s Year: 2004
Study of the connection between COPD, bronchial asthma and diabetes mellitus types 1 and 2 Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009
Longitudinal follow-up of pulmonary, nutritional and laboratory data in patients with cystic fibrosis related diabetes mellitus (CFRD) after initial treatment with glibenclamid Source: Eur Respir J 2003; 22: Suppl. 45, 229s Year: 2003
Pulmonary hypertension associated with neurofibromatosis type 1 Source: Eur Respir Rev, 27 (149) 180053; 10.1183/16000617.0053-2018 Year: 2018
Frequency and pecularities of flow pulmonary tuberculosis (PT) in patients with different forms of diabetes mellitus (DM) in up-to-date conditions Source: Eur Respir J 2002; 20: Suppl. 38, 363s Year: 2002
The influence of diabetes type 2 (D2 ) on pulmonary hypertension (PH) in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 60s Year: 2005
Cystic fibrosis related diabetes (CFRD) and diabetic control as a determinant of pulmonary function: fact or fiction? Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008
Type 2 diabetes mellitus risk associated with sarcoidosis: A Swedish population-based cohort study Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology Year: 2020
A study of the comorbidity of COPD and type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018